日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Cross-disciplinary perspectives on the potential for artificial intelligence across chemistry

跨学科视角探讨人工智能在化学领域的应用潜力

Mroz, Austin M; Basford, Annabel R; Hastedt, Friedrich; Jayasekera, Isuru Shavindra; Mosquera-Lois, Irea; Sedgwick, Ruby; Ballester, Pedro J; Bocarsly, Joshua D; Antonio Del Río Chanona, Ehecatl; Evans, Matthew L; Frost, Jarvist M; Ganose, Alex M; Greenaway, Rebecca L; Kuok Mimi Hii, King; Li, Yingzhen; Misener, Ruth; Walsh, Aron; Zhang, Dandan; Jelfs, Kim E

MolPrice: assessing synthetic accessibility of molecules based on market value

MolPrice:基于市场价值评估分子的合成可及性

Hastedt, Friedrich; Hellgardt, Klaus; Yaliraki, Sophia; Zhang, Dongda; Del Rio Chanona, Antonio

Primary and secondary caregiver burden of cognitive impairment associated with schizophrenia: a qualitative study based on caregiver interviews

精神分裂症相关认知障碍对主要和次要照护者的负担:一项基于照护者访谈的定性研究

Tulliez, Sébastien; Girardi, Alessandra; Ridley, Matthew; Rudell, Katja; Correll, Christoph U; Goldring, Abraham; Hastedt, Claudia; Keefe, Richard S E; Reuteman-Fowler, Corey

Mind the Gap: Executive Function Is Associated with the Discrepancy Between Cognitive and Adaptive Functioning in Autistic Children Without Cognitive Delay

弥合差距:执行功能与无认知延迟的自闭症儿童的认知功能和适应功能之间的差异有关

Braverman, Yael; Edmunds, Sarah R; Hastedt, Ingrid; Faja, Susan

Effectiveness, Engagement, and Safety of a Digital Therapeutic (CT-155/BI 3972080) for Treating Negative Symptoms in People With Schizophrenia: Protocol for the Phase 3 CONVOKE Randomized Controlled Trial

数字疗法(CT-155/BI 3972080)治疗精神分裂症患者阴性症状的有效性、参与度和安全性:3期CONVOKE随机对照试验方案

Lakhan, Shaheen E; Dorner-Ciossek, Cornelia; Besedina, Olya; Dickerson, Faith; Hastedt, Claudia; Isla, Ridwana; Kahn, René S; Lindenmayer, Jean-Pierre; Mehta, Ruchi; Snipes, Cassandra; Speier, Austin; Tang, Wenbo; Willis, Bailey; Fernandez, Jamie Winderbaum; von der Goltz, Christoph; Pratap, Abhishek

Psychometric evaluation of the patient-reported experience of cognitive impairment in schizophrenia (PRECIS) scale

精神分裂症患者自述认知障碍体验(PRECIS)量表的心理测量学评价

Lenderking, William R; Atkinson, Mark J; Ladd, Mary Kate; Savva, Yulia; Sommer, Stephanie; Sidovar, Matthew; Hastedt, Claudia

Associations of preschool reactive bed-sharing with sociodemographic factors, sleep disturbance, and psychopathology

学龄前儿童反应性同床睡眠与社会人口因素、睡眠障碍和精神病理学之间的关联

Marakovitz, Susan E; Sheldrick, R Christopher; Copeland, William E; Restrepo, Bibiana; Hastedt, Ingrid; Carpenter, Kimberly L H; McGinnis, Ellen W; Egger, Helen L

Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale

精神分裂症认知障碍的社会效用:基于精神分裂症认知评定量表开发一种基于偏好的评分算法

Santi, Irene; Lloyd, Andrew J; Hastedt, Claudia E; Versteegh, Matthijs M

iBCS: 2. Mechanistic Modeling of Pulmonary Availability of Inhaled Drugs versus Critical Product Attributes

iBCS:2.吸入药物肺部利用率与关键产品属性的机制模型

Bäckman, Per; Cabal, Antonio; Clark, Andy; Ehrhardt, Carsten; Forbes, Ben; Hastedt, Jayne; Hickey, Anthony; Hochhaus, Guenther; Jiang, Wenlei; Kassinos, Stavros; Kuehl, Philip J; Prime, David; Son, Yoen-Ju; Teague, Simon P; Tehler, Ulrika; Wylie, Jennifer

iBCS: 1. Principles and Framework of an Inhalation-Based Biopharmaceutics Classification System

iBCS:1. 吸入式生物药剂分类系统的原则和框架

Hastedt, Jayne E; Bäckman, Per; Cabal, Antonio; Clark, Andy; Ehrhardt, Carsten; Forbes, Ben; Hickey, Anthony J; Hochhaus, Guenther; Jiang, Wenlei; Kassinos, Stavros; Kuehl, Philip J; Prime, David; Son, Yoen-Ju; Teague, Simon; Tehler, Ulrika; Wylie, Jennifer